By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Heptares 

1-3 Burtonhole Lane, Mill Hill

London    NW7 1AD  United Kingdom
Phone: 44-0-20-8906-7100 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Discovery





Company News
Heptares Plans Relocation To Cambridge, UK 6/20/2017 9:00:36 AM
Heptares Solves First Full-Length Structure Of GLP-1 Receptor Bound To Peptide Agonist 6/1/2017 9:08:36 AM
Heptares’ Co-Founder And Chief Scientific Officer, Fiona Marshall, Receives 2017 John Daly Lecture Award In Recognition Of Her Outstanding Contribution To GPCR Drug Discovery 5/18/2017 12:57:02 PM
Heptares To Receive U.S.$5 Million Milestone Payment From Teva (TEVA) 5/18/2017 9:50:49 AM
Heptares Collaboration With AstraZeneca PLC (AZN) Yields New Insights To Advance Drug Discovery In Pain, Cancer And Inflammation 4/27/2017 6:49:09 AM
Sosei Subsidiary Heptares To Receive $12 Million Milestone Payment From AstraZeneca PLC (AZN) 4/5/2017 8:08:53 AM
Heptares Enters Agreement With Daiichi Sankyo To Discover And Develop Novel, Small-Molecules For The Treatment Of Pain 3/13/2017 6:47:57 AM
Heptares Enters A New Research Collaboration Under Its 'Orbit' Initiative With The University of Cambridge 1/31/2017 6:58:39 AM
Heptares Scientists Solve Structure Of CCR9 Chemokine Receptor Offering Unique Opportunity To Apply Structure-Based Design Across Chemokine Receptor Family 12/8/2016 9:09:15 AM
Heptares To Acquire G7 Therapeutics AG To Extend Leadership In GPCR-Focused Drug Discovery And Development 11/30/2016 9:39:07 AM
12345678
//-->